Cargando…
Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients
Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383292/ https://www.ncbi.nlm.nih.gov/pubmed/37513748 http://dx.doi.org/10.3390/pathogens12070901 |
_version_ | 1785080873659400192 |
---|---|
author | Udvardy, Miklós Illés, Árpád Gergely, Lajos Pinczés, László Imre Magyari, Ferenc Simon, Zsófia |
author_facet | Udvardy, Miklós Illés, Árpád Gergely, Lajos Pinczés, László Imre Magyari, Ferenc Simon, Zsófia |
author_sort | Udvardy, Miklós |
collection | PubMed |
description | Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing, so during the last decade, many, sometimes exotic, new pathogens and diseases were recorded and analyzed, and some of them were proved to be transmitted with transfusions. Blood or blood component transfusions are carried out after cautious preparative screening and inactivation maneuvers, but in some instances, newly recognized agents might escape from standard screening and inactivation procedures. Here, we try to focus on some of these proven or potentially pathogenic transfusion-transmitted agents, especially in immunocompromised patients or bone marrow transplantation settings. These pathogens are sometimes new challenges for preparative procedures, and there is a need for more recent, occasionally advanced, screening and inactivation methods to recognize and eliminate the threat a new or well-known pathogen can pose. Pathogen transmission is probably even more critical in hemophiliacs or bone marrow transplant recipients, who receive plasma-derived factor preparations or blood component transfusions regularly and in large quantities, sometimes in severely immunosuppressed conditions. Moreover, it may not be emphasized enough that transfusions and plasma-derived product administrations are essential to medical care. Therefore, blood-borne transmission needs continued alertness and efforts to attain optimal benefits with minimized hazards. |
format | Online Article Text |
id | pubmed-10383292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103832922023-07-30 Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients Udvardy, Miklós Illés, Árpád Gergely, Lajos Pinczés, László Imre Magyari, Ferenc Simon, Zsófia Pathogens Review Transfusion medicine is traditionally a strong/fundamental part of clinical practice, saving hundreds of millions of lives. However, blood-borne or transmitted infections are a well-known and feared possibility, a risk we relentlessly mitigate. Pathogens are continuously and rather quickly changing, so during the last decade, many, sometimes exotic, new pathogens and diseases were recorded and analyzed, and some of them were proved to be transmitted with transfusions. Blood or blood component transfusions are carried out after cautious preparative screening and inactivation maneuvers, but in some instances, newly recognized agents might escape from standard screening and inactivation procedures. Here, we try to focus on some of these proven or potentially pathogenic transfusion-transmitted agents, especially in immunocompromised patients or bone marrow transplantation settings. These pathogens are sometimes new challenges for preparative procedures, and there is a need for more recent, occasionally advanced, screening and inactivation methods to recognize and eliminate the threat a new or well-known pathogen can pose. Pathogen transmission is probably even more critical in hemophiliacs or bone marrow transplant recipients, who receive plasma-derived factor preparations or blood component transfusions regularly and in large quantities, sometimes in severely immunosuppressed conditions. Moreover, it may not be emphasized enough that transfusions and plasma-derived product administrations are essential to medical care. Therefore, blood-borne transmission needs continued alertness and efforts to attain optimal benefits with minimized hazards. MDPI 2023-07-01 /pmc/articles/PMC10383292/ /pubmed/37513748 http://dx.doi.org/10.3390/pathogens12070901 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Udvardy, Miklós Illés, Árpád Gergely, Lajos Pinczés, László Imre Magyari, Ferenc Simon, Zsófia Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title | Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title_full | Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title_fullStr | Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title_full_unstemmed | Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title_short | Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients |
title_sort | transfusion-transmitted disorders 2023 with special attention to bone marrow transplant patients |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383292/ https://www.ncbi.nlm.nih.gov/pubmed/37513748 http://dx.doi.org/10.3390/pathogens12070901 |
work_keys_str_mv | AT udvardymiklos transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients AT illesarpad transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients AT gergelylajos transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients AT pinczeslaszloimre transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients AT magyariferenc transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients AT simonzsofia transfusiontransmitteddisorders2023withspecialattentiontobonemarrowtransplantpatients |